Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 2Phase 4 2Phase 2 2

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Sarcoma 1Head & Neck 1

Conditions

Venous Thromboembolism 2Thrombosis 2Hemorrhage 2Venous Thrombosis 1Thromboembolism 1Thrombocytopenia 1Sarcoma 1Pulmonary Embolism 1Pancreatic Neoplasms 1Liver Neoplasms 1Hematoma 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Hepatocellular 1Bone Neoplasms 1

Interventions

apixaban 3Enoxaparin 2Aspirin 2sotorasib 1Rosuvastatin Calcium 1Rivaroxaban 1Dalteparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Venous Thromboembolism × Enoxaparin × Clear all
NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡